These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 10328075)
1. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. Inglesby TV; Henderson DA; Bartlett JG; Ascher MS; Eitzen E; Friedlander AM; Hauer J; McDade J; Osterholm MT; O'Toole T; Parker G; Perl TM; Russell PK; Tonat K JAMA; 1999 May; 281(18):1735-45. PubMed ID: 10328075 [TBL] [Abstract][Full Text] [Related]
3. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. Inglesby TV; Dennis DT; Henderson DA; Bartlett JG; Ascher MS; Eitzen E; Fine AD; Friedlander AM; Hauer J; Koerner JF; Layton M; McDade J; Osterholm MT; O'Toole T; Parker G; Perl TM; Russell PK; Schoch-Spana M; Tonat K JAMA; 2000 May; 283(17):2281-90. PubMed ID: 10807389 [TBL] [Abstract][Full Text] [Related]
4. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. Henderson DA; Inglesby TV; Bartlett JG; Ascher MS; Eitzen E; Jahrling PB; Hauer J; Layton M; McDade J; Osterholm MT; O'Toole T; Parker G; Perl T; Russell PK; Tonat K JAMA; 1999 Jun; 281(22):2127-37. PubMed ID: 10367824 [TBL] [Abstract][Full Text] [Related]
5. Tularemia as a biological weapon: medical and public health management. Dennis DT; Inglesby TV; Henderson DA; Bartlett JG; Ascher MS; Eitzen E; Fine AD; Friedlander AM; Hauer J; Layton M; Lillibridge SR; McDade JE; Osterholm MT; O'Toole T; Parker G; Perl TM; Russell PK; Tonat K; JAMA; 2001 Jun; 285(21):2763-73. PubMed ID: 11386933 [TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin as a biological weapon: medical and public health management. Arnon SS; Schechter R; Inglesby TV; Henderson DA; Bartlett JG; Ascher MS; Eitzen E; Fine AD; Hauer J; Layton M; Lillibridge S; Osterholm MT; O'Toole T; Parker G; Perl TM; Russell PK; Swerdlow DL; Tonat K; JAMA; 2001 Feb; 285(8):1059-70. PubMed ID: 11209178 [TBL] [Abstract][Full Text] [Related]
7. Hemorrhagic fever viruses as biological weapons: medical and public health management. Borio L; Inglesby T; Peters CJ; Schmaljohn AL; Hughes JM; Jahrling PB; Ksiazek T; Johnson KM; Meyerhoff A; O'Toole T; Ascher MS; Bartlett J; Breman JG; Eitzen EM; Hamburg M; Hauer J; Henderson DA; Johnson RT; Kwik G; Layton M; Lillibridge S; Nabel GJ; Osterholm MT; Perl TM; Russell P; Tonat K; JAMA; 2002 May; 287(18):2391-405. PubMed ID: 11988060 [TBL] [Abstract][Full Text] [Related]
8. Surveillance for adverse events associated with anthrax vaccination--U.S. Department of Defense, 1998-2000. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2000 Apr; 49(16):341-5. PubMed ID: 10817479 [TBL] [Abstract][Full Text] [Related]
9. Bacillus anthracis: medical issues of biologic warfare. Ibrahim KH; Brown G; Wright DH; Rotschafer JC Pharmacotherapy; 1999 Jun; 19(6):690-701. PubMed ID: 10391414 [TBL] [Abstract][Full Text] [Related]
10. Public health and bioterrorism: renewed threat of anthrax and smallpox. Wallin A; Luksiene Z; Zagminas K; Surkiene G Medicina (Kaunas); 2007; 43(4):278-84. PubMed ID: 17485954 [TBL] [Abstract][Full Text] [Related]
11. [Anthrax. The pathogen, the disease picture and possible use as a biological weapon]. Plettenberg A; Stoehr A; Meigel W Hautarzt; 2001 Dec; 52(12):1075-8. PubMed ID: 11910856 [No Abstract] [Full Text] [Related]
12. Military stays in Bosnia; vaccinates for anthrax. Gunby P JAMA; 1998 Jan; 279(4):260-1. PubMed ID: 9450696 [No Abstract] [Full Text] [Related]
14. From the Centers for Disease Control and Prevention. Surveillance for adverse effects associated with anthrax vaccination--US Department of Defense, 1998-2000. JAMA; 2000 May 24-31; 283(20):2648-9. PubMed ID: 10847805 [No Abstract] [Full Text] [Related]
15. Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. Friedlander AM; Pittman PR; Parker GW JAMA; 1999 Dec; 282(22):2104-6. PubMed ID: 10591317 [No Abstract] [Full Text] [Related]
16. Anthrax vaccine. Model of a response to the biologic warfare threat. Nass M Infect Dis Clin North Am; 1999 Mar; 13(1):187-208, viii. PubMed ID: 10198799 [TBL] [Abstract][Full Text] [Related]
17. Anthrax vaccination is based on medical evidence. Blanck RR Am J Public Health; 2000 Aug; 90(8):1326-7. PubMed ID: 10937023 [No Abstract] [Full Text] [Related]
18. Preparedness for an anthrax attack. Franz DR Mol Aspects Med; 2009 Dec; 30(6):503-10. PubMed ID: 19619577 [TBL] [Abstract][Full Text] [Related]
19. Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women. Meaney-Delman D; Zotti ME; Creanga AA; Misegades LK; Wako E; Treadwell TA; Messonnier NE; Jamieson DJ; Emerg Infect Dis; 2014 Feb; 20(2):. PubMed ID: 24457117 [TBL] [Abstract][Full Text] [Related]
20. Responding to the threat of bioterrorism: a microbial ecology perspective--the case of anthrax. Atlas RM Int Microbiol; 2002 Dec; 5(4):161-7. PubMed ID: 12497181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]